璞泰來(603659.SH):與安徽利科設浙江利科、加速推進生物基芳綸材料在隔膜塗覆加工領域的產業化應用
格隆匯2月16日丨璞泰來(603659.SH)公佈,鑑於公司近期與安徽利科新材料科技有限公司(“安徽利科”)簽署《關於浙江利科新材料科技有限公司的股東協議》,雙方共同發起設立浙江利科,加速推進生物基芳綸材料在隔膜塗覆加工領域的產業化應用。註冊資本5000萬元,其中公司認繳出資2000萬元,認繳出資比例40%。2023年2月15日,浙江利科取得市場監督管理局頒發的營業執照。
安徽利科是國內領先的生物基材料企業,擁有強大的研發和產品技術佈局,此次公司與安徽利科合資新設子公司浙江利科,有利於結合雙方在鋰電池材料領域和生物基領域的產業優勢和研發優勢,共同推動生物基芳綸塗布工藝和生產工藝的產業化和規模化應用,佈局研發新型芳綸塗覆工藝和產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.